Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

National cholesterol education program keeps a priority on lifestyle modification to decrease cardiovascular disease

Nancy D Ernst1, James I Cleeman

  • 1Ernst@rivnet.net

Current Opinion in Lipidology
|January 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fifteen years after To Err is Human: a success story to learn from.

BMJ quality & safety·2015
Same author

Introduction: From science to implementation: The Agency for Healthcare Research and Quality's program to prevent healthcare-associated infections-results and lessons learned.

American journal of infection control·2014
Same author

Introduction to "preventing healthcare-associated infections: results and lessons learned from AHRQ's HAI program".

Infection control and hospital epidemiology·2014
Same author

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

Circulation·2009
Same author

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary.

Critical pathways in cardiology·2008
Same author

Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary.

Cardiology in review·2006
Same journal

Editorial introduction.

Current opinion in lipidology·2026
Same journal

Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.

Current opinion in lipidology·2026
Same journal

Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis.

Current opinion in lipidology·2026
Same journal

The role of metabolic profiling and dietary intervention in the early diagnosis and prevention of atherosclerosis.

Current opinion in lipidology·2026
Same journal

A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients?

Current opinion in lipidology·2026
Same journal

Inflammation and atherosclerotic cardiovascular disease: where do we go from here?

Current opinion in lipidology·2026
See all related articles

The latest cholesterol guidelines focus on primary prevention of heart disease in high-risk individuals. They emphasize intensive cholesterol-lowering therapy, including lifestyle changes and medication, for better clinical management.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Clinical Guidelines

Background:

  • The National Cholesterol Education Program (NCEP) has released its third Adult Treatment Panel (ATP III) report.
  • This report builds upon previous NCEP ATP guidelines for cholesterol management.
  • It incorporates the latest clinical trial evidence.

Purpose of the Study:

  • To update clinical guidelines for cholesterol testing and management.
  • To introduce a primary prevention focus for coronary heart disease (CHD) in individuals with multiple risk factors.
  • To provide evidence-based recommendations for therapeutic lifestyle changes and pharmacologic treatment.

Main Methods:

  • Review and synthesis of current clinical trial evidence.
  • Development of updated clinical recommendations based on expert consensus.

Related Experiment Videos

  • Focus on risk stratification for primary prevention of CHD.

    • Main Results:

    • The ATP III report introduces a significant focus on primary prevention of CHD.
    • Guidelines support intensive cholesterol-lowering therapy for high-risk patients.
    • Recommendations cover both medical nutrition therapy (therapeutic lifestyle changes) and drug therapy.

    Conclusions:

    • The NCEP ATP III guidelines offer a comprehensive approach to cholesterol management.
    • Emphasis on primary prevention aims to reduce CHD incidence in at-risk populations.
    • The guidelines provide a framework for informed clinical judgment in treating high blood cholesterol.